Meyka Pro banner
IM Cannabis Corp.

IM Cannabis Corp. Fundamental Analysis (NASDAQ: IMCC)

IMCCNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$4.23
$2.49(143.10%)
U.S. Market opens in 28h 37m

IM Cannabis Corp. Fundamental Analysis (NASDAQ: IMCC)

IM Cannabis Corp. (NASDAQ: IMCC) shows weak financial fundamentals with a PE ratio of -0.17, profit margin of -38.11%, and ROE of 8.42%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio0.00

Areas of Concern

ROE8.42%
Operating Margin-25.96%
Cash Position4.45%
Current Ratio0.56
We analyze IMCC's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 34.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
34.0/100

We analyze IMCC's fundamental strength across five key dimensions:

Efficiency Score

Weak

IMCC struggles to generate sufficient returns from assets.

ROA > 10%
-63.74%

Valuation Score

Excellent

IMCC trades at attractive valuation levels.

PE < 25
-0.17
PEG Ratio < 2
0.00

Growth Score

Weak

IMCC faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

IMCC shows balanced financial health with some risks.

Debt/Equity < 1
-2.50
Current Ratio > 1
0.56

Profitability Score

Weak

IMCC struggles to sustain strong margins.

ROE > 15%
8.42%
Net Margin ≥ 15%
-38.11%
Positive Free Cash Flow
No

Key Financial Metrics

Is IMCC Expensive or Cheap?

P/E Ratio

IMCC trades at -0.17 times earnings. This suggests potential undervaluation.

-0.17

PEG Ratio

When adjusting for growth, IMCC's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values IM Cannabis Corp. at -9.83 times its book value. This may indicate undervaluation.

-9.83

EV/EBITDA

Enterprise value stands at 1.03 times EBITDA. This is generally considered low.

1.03

How Well Does IMCC Make Money?

Net Profit Margin

For every $100 in sales, IM Cannabis Corp. keeps $-38.11 as profit after all expenses.

-38.11%

Operating Margin

Core operations generate -25.96 in profit for every $100 in revenue, before interest and taxes.

-25.96%

ROE

Management delivers $8.42 in profit for every $100 of shareholder equity.

8.42%

ROA

IM Cannabis Corp. generates $-63.74 in profit for every $100 in assets, demonstrating efficient asset deployment.

-63.74%

Following the Money - Real Cash Generation

Operating Cash Flow

IM Cannabis Corp. generates limited operating cash flow of $-154.17K, signaling weaker underlying cash strength.

$-154.17K

Free Cash Flow

IM Cannabis Corp. generates weak or negative free cash flow of $-155.05K, restricting financial flexibility.

$-155.05K

FCF Per Share

Each share generates $-0.26 in free cash annually.

$-0.26

FCF Yield

IMCC converts -65.41% of its market value into free cash.

-65.41%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.17

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.001

vs 25 benchmark

P/B Ratio

Price to book value ratio

-9.83

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.09

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-2.50

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.56

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

8.42

vs 25 benchmark

ROA

Return on assets percentage

-0.64

vs 25 benchmark

ROCE

Return on capital employed

2.29

vs 25 benchmark

How IMCC Stacks Against Its Sector Peers

MetricIMCC ValueSector AveragePerformance
P/E Ratio-0.1731.31 Better (Cheaper)
ROE841.81%526.00% Excellent
Net Margin-38.11%21528.00% Weak
Debt/Equity-2.500.53 Strong (Low Leverage)
Current Ratio0.565.62 Weak Liquidity
ROA-63.74%-105.00% (disorted) Weak

IMCC outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROE, but lagging in Net Margin.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews IM Cannabis Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ